Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Investors make a beeline for WuXi AppTec shares

    By Cai Xiao | China Daily | Updated: 2018-05-26 11:51
    Share
    Share - WeChat
    Interior view of the headquarters of WuXi Biologics' parent firm, WuXi AppTec, in Shanghai, April 23, 2018. [Photo/IC]

    Leading contract research outsourcing provider WuXi AppTec saw its A-share price jump by the daily limit of 10 percent again on Friday after 13 consecutive trading days of gains to 107.36 yuan ($16.80).

    The market capitalization of the newly listed company totaled 111.9 billion yuan on Friday, ranked fifth by market capitalization among A-share listed pharmaceutical and biotechnology companies.

    Jiangsu Hengrui Medicine Co Ltd, Kangmei Pharmaceutical Co Ltd, Yunnan Baiyao Group Co Ltd and Shanghai Fosun Pharmaceutical Group Co Ltd were the other four firms.

    WuXi AppTec became the most profitable new share as investors could earn about 86,000 yuan for every 1,000 shares based on Friday's stock performance.

    The trading volume of WuXi AppTec totaled 272 million yuan on Friday, compared with 57.6 million yuan on Thursday.

    WuXi AppTec released a statement on Friday afternoon to remind investors of paying attention to the company's operating risks after 14 consecutive trading days of gains.

    "The nation levied no tariffs on imported anti-cancer drugs, as well as imported potency drugs, which also forced domestic drug manufacturers to upgrade their products, creating great opportunities for contract research organizations, with WuXi AppTec taking a lead.

    "Besides, as the market is opening up, there are limited enterprises that are able to offer qualified products, this explains why the company is favored by investors," said Chen Qiaoshan, senior medical analyst at Beijing-based internet consultancy Analysys.

    WuXi AppTech, formerly known as WuXi PharmaTech (Cayman) Inc, was listed at the New York Stock Exchange in 2007 and went private in 2015. WuXi PharmaTech (Cayman) Inc was divided into three companies then: Pharmaceutical Co Ltd listed at China's new third board in 2015, Wuxin Biologics went public in Hong Kong in 2017 and WuXi AppTech, which was listed in May.

    Zheng Yiran contributed to this story.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    在线欧美天码中文字幕| 日日麻批免费40分钟无码| 人妻丰满熟妞av无码区| 久久精品中文騷妇女内射| 国产AV无码专区亚洲精品| 中文字幕无码久久人妻| 中文有码vs无码人妻| 日韩成人无码影院| 人妻少妇精品无码专区二区| 国模无码人体一区二区| 国产欧美日韩中文字幕 | 无码精品人妻一区二区三区免费看| 日本精品中文字幕| 日韩av无码中文无码电影| 88国产精品无码一区二区三区 | 亚洲va无码专区国产乱码| 亚洲精品97久久中文字幕无码| 人妻无码αv中文字幕久久琪琪布| av大片在线无码免费| 无码国产精品一区二区免费16| 国产午夜精华无码网站| 中文字幕无码不卡免费视频 | 日本高清不卡中文字幕免费| 在线综合亚洲中文精品| 无码人妻一区二区三区精品视频| 50岁人妻丰满熟妇αv无码区| 免费看又黄又无码的网站 | 永久免费无码日韩视频| 久久国产三级无码一区二区| 2024你懂的网站无码内射| 国产av无码专区亚洲av桃花庵| 国产成人午夜无码电影在线观看| 免费无码一区二区三区| 国99精品无码一区二区三区| 国模无码一区二区三区| 亚洲一区无码精品色| 中文有无人妻vs无码人妻激烈| 人妻无码αv中文字幕久久| 日本乱中文字幕系列观看| 欧美日韩中文字幕在线观看| 久久亚洲精品无码aⅴ大香|